Results 11 to 20 of about 1,324,041 (317)

Association of Receipt of Opioid Use Disorder–Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic

JAMA psychiatry, 2023
Key Points Question Were new federal authorities to expand telehealth use for substance use disorder treatment and to facilitate provision of medications for opioid use disorder (MOUD) during the COVID-19 pandemic associated with a lower risk for fatal ...
Christopher M. Jones, Carla Shoff, Carlos Blanco, J. Losby, Shari M. Ling, W. Compton   +5 more
semanticscholar   +1 more source

Medications for opioid use disorder during incarceration and post-release outcomes

Health & Justice, 2023
Background Continuation or initiation of MOUDs during incarceration could improve post-release outcomes by preventing return to opioid use and reducing risk of overdose.
Lara Cates, Aaron R. Brown
semanticscholar   +1 more source

Trends in Before Medically Advised Discharges for Patients With Opioid Use Disorder, 2016-2020.

Journal of the American Medical Association (JAMA), 2023
This study examines discharge trends for opioid-related admissions from 2016-2020 with a focus on admissions with opioid use disorder and an injection-related infection.
Ashish P. Thakrar, Margaret Lowenstein, S. R. Greysen, M. Delgado   +3 more
semanticscholar   +1 more source

U.S. student pharmacist perceptions of the pharmacist’s role in methadone for opioid use disorder: A qualitative study

SAGE Open Medicine, 2021
Background: Of the over 20 million Americans reporting an opioid use disorder, only around 3 million report receiving treatment of any kind. The gold standard for opioid use disorder treatment is medication in combination with psychosocial support, but ...
Kenneth C Hohmeier, Alina Cernasev, Megan Sensmeier, Elizabeth Hall, Katie Webb, Rachel Barenie, Gerald Cochran   +6 more
doaj   +1 more source

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees

JAMA Network Open, 2023
Key Points Question Was telemedicine initiation for buprenorphine treatment associated with changes in treatment retention or opioid-related nonfatal overdose?
Lindsey R. Hammerslag, Aimee Mack, Redonna K. Chandler, Laura C. Fanucchi, Daniel J. Feaster, Marc R. Larochelle, Michelle R. Lofwall, Michael Nau, Jennifer Villani, Sharon L. Walsh, P. Westgate, S. Slavova, Jeffery Talbert   +12 more
semanticscholar   +1 more source

Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019

JAMA Network Open, 2022
This cross-sectional study of respondents to the National Survey on Drug Use and Health evaluates rates of medication for opioid use disorder receipt among people with need for treatment as well as associated sociodemographic characteristics.
P. Mauro, Sarah Gutkind, Erin Annunziato, Hillary Samples   +3 more
semanticscholar   +1 more source

The Impact of Stigma on People with Opioid Use Disorder, Opioid Treatment, and Policy

Substance Abuse and Rehabilitation, 2022
Illicit drug use disorders are the most stigmatised health conditions worldwide, and stigma acts as a meaningful barrier to treatment entry and treatment provision.
A. Cheetham, L. Picco, A. Barnett, D. Lubman, S. Nielsen   +4 more
semanticscholar   +1 more source

Opioid Use Disorder in Women and the Implications for Treatment

Psychiatric Research and Clinical Practice, 2021
Objective The opioid epidemic continues to evolve and impact all groups of people. Moreover, there are concerning trends among women. The aim of this article is to provide a review of opioid use disorder in women and the implications for treatment ...
Celestina Barbosa‐Leiker, Aimee N. C. Campbell, R. Kathryn McHugh, Constance Guille, Shelly F. Greenfield   +4 more
doaj   +1 more source

Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder

JAMA Network Open, 2020
This comparative effectiveness research study examines associations between opioid use disorder treatment pathways and overdose and opioid-related acute care use as proxies for opioid use disorder recurrence.
S. Wakeman, Marc R. Larochelle, O. Ameli, C. Chaisson, J. Mcpheeters, W. Crown, F. Azocar, Darshak M Sanghavi   +7 more
semanticscholar   +1 more source

Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.

New England Journal of Medicine, 2022
BACKGROUND Opioid agonist therapy is strongly recommended for pregnant persons with opioid use disorder. Buprenorphine may be associated with more favorable neonatal and maternal outcomes than methadone, but existing data are limited.
Elizabeth A. Suarez, K. Huybrechts, L. Straub, S. Hernández-Díaz, H. Jones, H. Connery, J. Davis, K. Gray, B. Lester, M. Terplan, H. Mogun, B. Bateman   +11 more
semanticscholar   +1 more source